"De locatie Erasmus MC-Daniel den Hoed bestaat niet meer. De patiëntenzorg is verhuisd naar Erasmus MC, Dr. Molewaterplein 40, 3015 GD Rotterdam."

During the past decade, Rotterdam Cancer Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rotterdam Cancer Institute" #1 collaborator was "Medical Research Council" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Rotterdam Cancer Institute" are "Unspecified Adult Solid Tumor, Protocol Specific" (6 trials), "Brain and Central Nervous System Tumors" (5 trials), "Lung Cancer" (3 trials), "Melanoma (Skin)" (3 trials) and "Sarcoma" (3 trials). Many other conditions were trialed in "Rotterdam Cancer Institute" in a lesser frequency.

Most popular intervention types in "Rotterdam Cancer Institute" are "Drug" (22 trials), "Radiation" (7 trials), "Biological" (6 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (6 trials), "cisplatin" (3 trials), "recombinant interferon alfa" (3 trials), "chemotherapy" (2 trials) and "doxorubicin hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rotterdam Cancer Institute" are 23 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Rotterdam Cancer Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Rotterdam Cancer Institute, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rotterdam Cancer Institute, 7 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".